Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection

Z Bahari, Z Jangravi, H Ghoshooni, MR Afarinesh… - Inflammation …, 2021 - Springer
Abstract Objective Coronavirus disease 2019 (COVID-19) is a world-wide pandemic caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, treatment of …

Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to …

AA Rabaan, SH Al-Ahmed, J Muhammad, A Khan… - Vaccines, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …

Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for thetreatment of hyperinflammation

A Tufan, M Matucci-Cerinic - Turkish Journal of Medical …, 2021 - journals.tubitak.gov.tr
In the Wuhan province of China, almost two years ago, in December 2019, the novel
Coronavirus 2019 has caused a severe involvement of the lower respiratory tract leading to …

Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features

F Rommasi, MJ Nasiri, M Mirsaeidi - Molecular and cellular biochemistry, 2022 - Springer
The novel coronavirus pandemic has emerged as one of the significant medical-health
challenges of the current century. The World Health Organization has named this new virus …

The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19

C Perricone, P Triggianese, E Bartoloni, G Cafaro… - Journal of …, 2020 - Elsevier
The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection has posed the world at a pandemic risk. Coronavirus-19 disease (COVID-19) is an …

Targeting cytokine storm to manage patients with COVID-19: a mini-review

N Roshanravan, F Seif, A Ostadrahimi… - Archives of medical …, 2020 - Elsevier
Corona Virus Disease 2019 (COVID-19) pandemic is rapidly spreading all over the world.
Excessive immune responses trigger life-threatening cytokine release syndrome (CRS) …

[PDF][PDF] Biochemical and immunological aspects of COVID-19 infection and therapeutical intervention of oral low dose cytokine therapy: a systematic review

M Ratheesh, S Sheethal, SP Jose, S Rajan… - Immunopharmacol …, 2021 - academia.edu
The novel coronavirus (SARS-CoV-2) pandemic has now spread to all corners of the world.
It causes severe respiratory syndromes which is one of the leading causes of death …

Pharmaco-immunomodulatory therapy in COVID-19

JG Rizk, K Kalantar-Zadeh, MR Mehra, CJ Lavie… - Drugs, 2020 - Springer
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …

Cytokine Storm and its Implication in Coronavirus disease 2019 (COVID-19)

C Datta, A Bhattacharjee - Journal of …, 2020 - immunologyresearchjournal.com
Abstract Corona virus disease 2019 (COVID-19), is a viral disease caused by novel corona
virus known as severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). The …

Immunomodulatory drugs in the management of SARS-CoV-2

DR Burrage, S Koushesh, N Sofat - Frontiers in immunology, 2020 - frontiersin.org
With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain …